Skip to main content
Log in

Halothane hepatitis with renal failure treated with hemodialysis and exchange transfusion

  • Published:
The Japanese journal of surgery Aims and scope Submit manuscript

Abstract

A 38-year-old white female, hepatitis B antigen negative, developed fluminating hepatic failure associated with oliguria and severe azotemia after two halothane anesthesia and without exposure to other hepatotoxic drugs or blood transfusions. She was treated with multiple hemodialysis and exchange blood transfusion. The combined treatment corrected the uremic abnormalities and improved her level of consciousness. The liver and kidney function gradually improved, and she made a complete recovery, the first recorded with hepatic and renal failure under these post-anesthetic conditions. Further evaluation of this combined treatment used for this patient is warranted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Carney, F. M. T. and Van Dyke, R. A.: Halothane hepatitis; a critical review. Anesth Analg. 51: 135–160, 1972.

    PubMed  CAS  Google Scholar 

  2. Castleman, B. and McNelly, B. U.: Case records of the Massachusetts General Hospital. Case 10. New. Engl. J. Med. 282: 558–564, 1970.

    Article  Google Scholar 

  3. Keynes, W. M.: Hemodialysis in the treatment of liver failure. Lancet 2: 1236–1238, 1968.

    Article  PubMed  CAS  Google Scholar 

  4. Kiley, J. E., Pender, J. C., Welch, H. F., and Welch, C. S.: Ammonia intoxication treated by hemodialysis. New. Engl. J. Med. 259: 1156–1161, 1958.

    Article  PubMed  CAS  Google Scholar 

  5. Peters, R. L., Edmondson, H. A., Reynolds, T. B., Meister, J. C. and Curphey, T. J.: Hepatic necrosis associated with halothane anesthesia. Amer. J. Med. 47: 748–764, 1969.

    Article  PubMed  CAS  Google Scholar 

  6. Redeker, A. G. and Hamahiro, H. S.: Controlled trial of exchange transfusion therapy in fulminant hepatitis. Lancet 1: 3–6, 1973.

    Article  PubMed  CAS  Google Scholar 

  7. Sherlock, S.: Hepatic coma. Gastroenterology 41: 1–8, 1961.

    Google Scholar 

  8. Tornetta, F. J., and Tamaki, T. H.: Halothane jaundice and hepatooxicity. J.A.M.A. 184: 658–660, 1963.

    PubMed  CAS  Google Scholar 

  9. Trey, C.: The fulminant hepatic failure surveillance study. Brief review of the effects of presumed etiology and age of survival. CMA J. 106: 525–527, 1972.

    CAS  Google Scholar 

  10. Weg, J. G., Harris, R. E., Miller, M. B., Wiltsie, D. S., McPhaul, J. J. and Finkel, M.: Treatment of hepatic coma by hemodialysis. Texas State J. Med. 60: 736–740, 1964.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by grants from the Veterans Administration; by grants RR-00051 and RR-00069 from the General Clinical Research Centers Program of the Division of Research Resources, National Institutes of Health; and by grants AM-07772 and AI-AM-08898 of the United States Public Health Service.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ishikawa, M., Popovtzer, M.M., Iwatsuki, S. et al. Halothane hepatitis with renal failure treated with hemodialysis and exchange transfusion. The Japanese Journal of Surgery 4, 212–215 (1974). https://doi.org/10.1007/BF02469454

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02469454

Key Words

Navigation